Blog
Got a PPP Loan for Your Business? Here Are 3 Updates You Need to Know About
Small businesses across the country have been struggling since March, when COVID-19 really took hold and many were forced to close their doors or change their business models. Thankfully, the
Should Sorrento Therapeutics Be Your Next Coronavirus Buy?
Sorrento Therapeutics (NASDAQ: SRNE) had good news for investors recently when it said its second candidate to fight coronavirus showed positive results in preclinical testing. That's after positive
Where Will Phillips 66 Be in 10 Years?
There may be more disruption taking place in the oil and gas industry today than at any time in the past 100 years. COVID-19 caused such a disruption in oil markets that oil futures prices went
Is Synchrony Financial a Buy While It's Down?
Synchrony Financial (NYSE: SYF), the financial institution that specializes in store-branded credit cards, was one of the most beaten-down stocks as the COVID-19 pandemic caused the U.S. economy to
So You Want To Be A Doctor? Take These 3 Steps First
It's no secret why young people everywhere aspire to become doctors. Society holds doctors in high esteem thanks to their lifesaving and life-prolonging services, their compassion, their scientific
45% of Workers Plan to Ease Into Retirement, and Here's Why You May Want to Do the Same
For some people, the transition from working to retirement is effectively a hard stop -- one day you're plugging away for eight hours at your desk, the next day you're a person of leisure whose days
The 1 Stock I'd Buy Right Now
I could pretty easily rattle off the names of at least 20 stocks that I think will be long-term winners. But if you asked me to narrow the list down to just the top three, it would take me a while
If You Invested $5,000 in Canopy Growth's IPO, This Is How Much Money You'd Have Now
Not every company can start out with the biggest market cap in its industry. But Canopy Growth (NYSE: CGC) did. How? It was the first publicly traded Canadian cannabis producer. And Canopy still
Buying These 3 Stocks Is a Brilliant Move to Make Right Now
Should I buy stocks? Should I hold off? Those are the questions that are probably going through may investors' minds right now. After the big stock market rebound over the last three months, it's
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Most of the buzz over Gilead Sciences (NASDAQ: GILD) in recent months has centered on its antiviral drug remdesivir. That's understandable, considering that the drug is currently the most promising
What's the Outlook for Moderna?
It's probably fair to say that no one in late 2019 would have foreseen the crazy ride that Moderna (NASDAQ: MRNA) has had so far this year. Global pandemics aren't all that easy to predict.
Moderna
3 Top Dividend Stocks to Buy Right Now
It's an interesting time in the stock markets to say the least. The S&P 500 is up 9% in the past three months, nearly making up for the crash that happened in March.
Despite millions of Americans
3 Pot Stocks to Stay Miles Away From
Tilray (NASDAQ: TLRY), HEXO (NYSE: HEXO), and MediPharm Labs (OTC: MEDIF) are three Canadian companies that have been popular cannabis stocks, but there are good reasons to avoid investing in them
Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?
The medical device sector took a hit this spring when patients were forced to postpone elective surgical procedures due to the coronavirus pandemic, and Medtronic (NYSE: MDT) and Boston Scientific
Who Can Donate Plasma for COVID-19 Patients?
People who had COVID-19 and are now fully recovered may be eligible to donate plasma to help patients currently infected with COVID-19. Their plasma likely contains antibodies that bind and inhibit
Donald Trump's Stimulus Plan Is a Double-Edged Sword
Over the past three-plus months, Americans have been challenged like never before. The coronavirus disease 2019 (COVID-19) pandemic has pushed the unemployment rate from near a 50-year low of sub-4%
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics
CRISPR Therapeutics (NASDAQ: CRSP) and Sangamo Therapeutics (NASDAQ: SGMO) are clinical-stage biotech companies aiming to capture a slice of the cell and gene therapy market, which will grow to be
2 Cannabis Stocks That Should Survive the COVID-19 Crisis
What's essential for businesses when a crisis like the COVID-19 pandemic hits is to keep operating and try to make it out of the crisis without running out of money. Almost all the sectors are
4 States Where Legalizing Marijuana Will Have to Wait Until 2021 or 2022
Despite all that's gone on in 2020, it's important not to lose sight of the fact that we're now less than five months away from Election Day. We'll see voters choose who'll be president of the
Did You Sell Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Last Week?
Cruise line stocks were big winners during the first week of June. The second week, they didn't fare as well. Shares of Carnival (NYSE: CCL) (NYSE: CUK), Norwegian Cruise Line Holdings (NYSE: NCLH)
44% of Americans Are Worried Small Businesses Won't Survive COVID-19. Do These Things If You Feel the Same.
With much of the country beginning to reopen after months of lockdown due to COVID-19, many consumers are celebrating the return of small businesses. But some may not be able to open their doors, or
Want to Keep Your Retirement Plans on Track? Invest During COVID-19
To say that the last few months have been a wild ride for investors would be an understatement. The year started out with one of the stock market's worst quarters in history, and investors watched
Better Buy: Lululemon vs. Stitch Fix
Lululemon (NASDAQ: LULU) and Stitch Fix (NASDAQ: SFIX) both weathered the retail apocalypse in unique ways. Lululemon's focus on high-end yoga apparel and community events locked in shoppers, while
These Stocks Would Have Doubled Your Money Last Year
It's something of a holy grail with investors -- the search for companies that can double your money. While that feat is impressive enough in its own right, it's even harder to find a growth stock



